High Throughput Screening of Drugs Based on 3Dmicroflu™
CD BioSciences is a growing life science company focusing on 3D bioprinting fields such as bio-ink design, 3D printing technology platform development and in vitro research micro-models customization. Here, our experienced experts can provide you with a series of 3d printing bioinks and solutions based on 3Dmicroflu™ technology platform for you to choose from according to your project needs. In the process of drug development, no matter what type of drug, models are needed for the initial drug screening. CD BioSciences can help you achieve high throughput in drug screening by replacing inaccurate 2D cell and animal models. Do you consider choosing 3Dmicroflu™ technology platform to advance your in vitro drug screening process? The following shows the application of 3Dmicroflu™ technology platform in advancing the drug screening development process.
Overview of drug screening
Drug screening is the process of assessing the biological activity, pharmacological action and medicinal value of substances that may be used as drugs, using appropriate methods. The process of drug preference is carried out within a certain range of available options. Thus, drug screening includes prescription screening in the process of new drug research, where drugs that meet the requirements are selected according to a specific purpose.
The selection of a suitable high-throughput in vitro screening model is important for the drug screening process. Here, CD BioSciences can provide you with high-resolution 3D bioprinting 3Dmicroflu™ technology platform based on microfluidic system that excellently helps you to construct the required in vitro screening models.
3Dmicroflu™ for the construction of the high-throughput in vitro drugs screening micro-models
3Dmicroflu™ technology platform can provide you with high-resolution 3D bioprinting services based on the microfluidic system that is involved in building models that truly reflect physiological characteristics. Currently, 3Dmicroflu™ technology platform can be applied to the screening process of vaccines, small molecule drugs, antibody drugs and cellular drugs.
The speed of vaccine development is of great importance for the control of outbreaks of infectious diseases. In vitro screening of vaccines has always been an important step in determining the progress and speed of development. Micro-models that truly reflect the physiological state are the best alternative to animal models. CD BioSciences can provide you with high-resolution 3Dmicroflu™ technology platform offering custom 3D printing of immune organ micro-models. 3Dmicroflu™ will not only meet your vaccine screening needs, but also accelerates your in vitro vaccine screening process.
Small molecules have a number of advantages that make them a major target for drug discovery and development, which are widely used in the treatment of various diseases. CD BioSciences can provide you with high-resolution in vitro disease micro-models for the screening of small molecule targeted drugs. The disease micro-models constructed by 3Dmicroflu™ technology platform not only allow for the discovery of new targets through disease mechanism studies, but also the high-throughput screening of small molecule drugs based on the identified targets.
The advantages of antibody drugs are specificity and functional flexibility for design and customization. CD BioSciences' proprietary 3D printing 3Dmicroflu™ technology platform can support and accelerate your antibody screening efforts by providing you with disease models and immune system models that truly reflect physiological states. For special and complex project needs, we have experienced experts available to consult with you.
Compared to traditional drugs, cellular drugs will be more effective and better suited for personalized therapeutic applications. 3Dmicroflu™ technology platform from CD BioSciences enables high-resolution 3D bioprinting for cell printing and drug screening model construction in cellular drug development. These screening models fully mimic the characteristics of physiological conditions, resulting in more realistic and effective screening results, which can avoid unnecessary cost and time wastage.
3Dmicroflu™ technology platform from CD BioSciences can contribute to the construction and design of models for drug screening for the above mentioned drugs that are already widely used and in hot projects of development. By facilitating the drug screening process, our high-resolution 3Dmicroflu™ technology platform can greatly accelerate the development of drugs and save more patients in a timely manner. This is what CD BioSciences is committed to doing and aiming to do.
If you have a need for the 3Dmicroflu™ technology platform for high-throughput screening of drugs in your drug development program, please feel free to contact us for customization of the in vitro micro-models construction. We always hope that 3Dmicroflu™ technology platform will provide great assistance and guidance to your drug development process.
For research use only, not intended for any clinical use.
